AlphaNeuro

New York, United States Founded: 2024 • Age: 2 yrs
Provider of AI-based platform for diagnosis and tracking of mental heath diseases and disorders
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 7 Brand Intelligence

About AlphaNeuro

AlphaNeuro is a company based in New York (United States) founded in 2024 by Brian Fischman. AlphaNeuro offers products and services including Ascendia Platform. AlphaNeuro operates in a competitive market with competitors including Combinostics, Neurobrave, Medical Brain, Nile and RedOak Instruments, among others.

  • Headquarter New York, United States
  • Founders Brian Fischman
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AlphaNeuro

AlphaNeuro offers a comprehensive portfolio of products and services, including Ascendia Platform.

Product name locked
Category locked
Primary

AI-assisted tools for clinicians to manage mental healthcare.

Funding Insights of AlphaNeuro

Premium access

Detailed funding history for AlphaNeuro

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AlphaNeuro

Investments
Premium access

Investment portfolio details for AlphaNeuro

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - AlphaNeuro

Premium access

Detailed financials for AlphaNeuro

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Alphaneuro Comparisons

AlphaNeuro Primary company
Description
Provider of AI-based platform for diagnosis and tracking of ...
Location
New York, United States
Founded Year
2024
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for AlphaNeuro

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of AlphaNeuro

AlphaNeuro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Combinostics, Neurobrave, Medical Brain, Nile and RedOak Instruments, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI-powered solutions for neurological disorder detection and management are developed.
Locked Locked Locked
Cloud-based neurology disease detection tool for healthcare professionals
Locked Locked Locked
Actionable insights for neurological conditions are generated via AI platform.
Locked Locked Locked
AI-based epilepsy management tools are provided to patients and providers.
Locked Locked Locked
Developer of device for injury and motor skills monitoring
Premium access

Detailed competitors of AlphaNeuro

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Alphaneuro

Premium access

Complete news archive for AlphaNeuro

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AlphaNeuro

AlphaNeuro was founded in 2024.

AlphaNeuro is headquartered in New York, United States. It is registered at New York, New York, United States.

Brian Fischman is the current CEO of AlphaNeuro. They have also founded this company.

Provider of AI-based platform for diagnosis and tracking of mental heath diseases and disorders. It offers a platform which provides therapeutic insight, decision support, analytics, and real-time analysis for mental health practitioners.

AlphaNeuro's top competitors include Combinostics, Medical Brain and Nile.

AlphaNeuro offers Ascendia Platform.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available